𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria

✍ Scribed by J. Zhou; Z. Wang; Z.-Q. Wu; S.-J. Qiu; Y. Yu; X.-W. Huang; Z.-Y. Tang; J. Fan

Book ID
116934277
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
319 KB
Volume
40
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sirolimus-based immunosuppression for li
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
✍ Norman M. Kneteman; JosΓ© Oberholzer; Mohammed Al Saghier; Glenda A. Meeberg; Mau πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 1 views

An increasing number of patients with hepatocellular carcinoma (HCC) are undergoing evaluation for listing for liver transplantation. Criteria for selection require ongoing review for suitability. A consecutive series of 40 patients with HCC within the standard Milan criteria (single tumors n = 19 <

Liver transplantation in patients with h
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
✍ J. Ignacio Herrero; Bruno Sangro; Fernando Pardo; Jorge Quiroga; Mercedes IΓ±arra πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 1 views

Milan criteria are the most frequently used limits for liver transplantation (LT) in patients with hepatocellular carcinoma (HCC), but our previous experience with expanded criteria showed encouraging results. The aim of this study was to investigate whether our expanded Clinica Universitaria de Nav

Sirolimus-based immunosuppression in liv
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
✍ Wenhua Liang; Dongping Wang; Xiaoting Ling; Andrew Allen Kao; Yuan Kong; Yushu S πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 786 KB

Sirolimus (SRL) is a novel immunosuppressant with antitumor properties. We performed a meta-analysis to determine whether SRL can improve patient survival and decrease the risks of tumor recurrence in patients with a pretransplant diagnosis of hepatocellular carcinoma (HCC). We searched databases fo

Sirolimus-based immunosuppression is ass
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
✍ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of